| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9662342 | EUGIA PHARMA SPECLTS | Formulations of cyclophosphamide liquid concentrate |
Jun, 2035
(11 years from now) | |
Cyclophosphamide is owned by Eugia Pharma Speclts.
Cyclophosphamide contains Cyclophosphamide.
Cyclophosphamide has a total of 1 drug patent out of which 0 drug patents have expired.
Cyclophosphamide was authorised for market use on 25 August, 2021.
Cyclophosphamide is available in solution;intravenous dosage forms.
The generics of Cyclophosphamide are possible to be released after 26 June, 2035.
Drugs and Companies using CYCLOPHOSPHAMIDE ingredient
Market Authorisation Date: 25 August, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
CYCLOPHOSPHAMIDE family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10849916 | DR REDDYS | Stable liquid formulations of cyclophosphamide and its impurities |
Jul, 2035
(11 years from now) | |
| US11382923 | DR REDDYS | Stable liquid formulations of cyclophosphamide and processes to prepare the same |
Dec, 2035
(12 years from now) | |
Cyclophosphamide is owned by Dr Reddys.
Cyclophosphamide contains Cyclophosphamide.
Cyclophosphamide has a total of 2 drug patents out of which 0 drug patents have expired.
Cyclophosphamide was authorised for market use on 07 June, 2023.
Cyclophosphamide is available in solution;intravenous dosage forms.
The generics of Cyclophosphamide are possible to be released after 01 December, 2035.
Drugs and Companies using CYCLOPHOSPHAMIDE ingredient
Market Authorisation Date: 07 June, 2023
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
CYCLOPHOSPHAMIDE family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10993952 | INGENUS PHARMS LLC | Stable ready to use cyclophosphamide liquid formulations |
Feb, 2036
(12 years from now) | |
Cyclophosphamide is owned by Ingenus Pharms Llc.
Cyclophosphamide contains Cyclophosphamide.
Cyclophosphamide has a total of 1 drug patent out of which 0 drug patents have expired.
Cyclophosphamide was authorised for market use on 30 July, 2020.
Cyclophosphamide is available in solution;intravenous dosage forms.
The generics of Cyclophosphamide are possible to be released after 15 February, 2036.
Drugs and Companies using CYCLOPHOSPHAMIDE ingredient
Market Authorisation Date: 30 July, 2020
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
CYCLOPHOSPHAMIDE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic